Author: IQ TIMES MEDIA
Vinod Khosla has his eye on one AI metric, and it’s not stock prices.On an episode of OpenAI’s podcast released on Monday, the famed venture capitalist shared how he’s gauging whether we’re in an AI bubble — or not.”People equate bubble to stock prices, which has nothing to do with anything other than fear and greed among investors,” he said. “So I always look at, bubbles should be measured by the number of API calls.”API, or Application Programming Interface calls, refer to the process in which one software application sends a message to another application to request data or to…
Advertising could become a $25 billion business for OpenAI — and pose a threat to Google, according to new estimates on Monday from a top tech analyst.Evercore ISI’s Mark Mahaney sees the startup generating that level of annual ad revenue by 2030 if it executes well on rolling out this new business.OpenAI said on Friday that free and Go users of ChatGPT would start seeing ads “in the coming weeks.” OpenAI also laid out its advertising principles, such as clearly labeling them and not sharing user conversations with advertisers.”A path to generating several billion dollars in ad revenue in 2026,…
Cases in the nation’s largest current measles outbreak are still ticking up after officials said infections have spread from the South into the Pacific Northwest.Washington state health officials on Jan. 16 confirmed an outbreak connected to a contagious family traveling from South Carolina. The Southern state has a major outbreak of the highly contagious viral disease, with nearly 250 new cases documented in a week’s span.The three cases in Washington are all among unvaccinated children in Snohomish County, just north of Seattle, according to the state’s health department. The children had fever, cough and rash, all common indicators of measles.…
OpenAI is going on all in on “practical adoption” of artificial intelligence in 2026, according to its CFO.”The priority is closing the gap between what AI now makes possible and how people, companies, and countries are using it day to day,” Sarah Friar wrote in a recent blog post.”The opportunity is large and immediate, especially in health, science, and enterprise, where better intelligence translates directly into better outcomes,” she added.There are signs the startup is already taking advantage of these opportunities. Data from Ramp showed that business spending on OpenAI models surged to a record in December, outpacing rivals Anthropic…
Many patients who contracted mpox during the 2022 outbreak experienced physical effects more than a year later, a new study published on Monday finds.Researchers from the Centers for Disease Control and Prevention (CDC), Columbia University’s division of Infectious siseases and the University of Texas Health Science Center looked at more than 300 adults who were either diagnosed with mpox between May 2022 and January 2023 or were at risk but never infected.California officials investigate possible local spread of mpox after 3 cases with no travel history reportedThey found that more than half — 58% — of those who were diagnosed…
Jan 19 (Reuters) – Pharmaceutical company Boehringer Ingelheim said on Monday the U.S. Food and Drug Administration had approved its chewable tablet, as the first drug to delay congestive heart failure in dogs with a type of early-stage heart disease.The approval covers dogs with a heart condition, known as myxomatous mitral valve disease, who show signs of heart enlargement but do not yet have symptoms.The FDA said Vetmedin can now be used to slow the progression of the disease before dogs develop heart failure.Vetmedin was first given conditional approval for this use in 2022, allowing it to be sold while…
Former “Bachelorette” star Katie Thurston, who is fighting breast cancer, is revealing that her mother has been diagnosed with breast cancer as well.Thurston shared the news with fans and followers on Instagram on Monday.”Life update: my mom has #breastcancer. I flew to Seattle this weekend to be with her at her first appointment,” Thurston wrote.”I want to make sure she is getting proper care and information. I hate that we have to be our biggest advocate but also, it’s what will save your life,” Thurston continued.ABC – PHOTO: Katie Thurston speaks with “Good Morning America” co-anchor Robin Roberts on Oct.…
Jan 19 (Reuters) – French drugmaker Valneva said on Monday it has voluntarily withdrawn its application seeking standard approval of its chikungunya vaccine in the United States after the FDA suspended the shot’s license in August, citing safety concerns.The specialty vaccine-maker said it was also informed by the U.S. Food and Drug Administration that the agency was placing its application for further clinical trials of the vaccine, Ixchiq, on hold pending investigation of a newly reported serious adverse event.The company, which said it had been waiting for further information on its formal response to the vaccine license suspension, added that…
The AI industry entered 2025 with strong momentum. There were 49 startups that raised funding rounds worth $100 million or more in 2024, per our count at TechCrunch; three companies raised more than one “mega-round,” and seven companies raised rounds that were $1 billion in size or larger. The industry didn’t slow down in 2025. While less companies raised rounds larger than $1 billion, four — Anthropic raised two rounds over $1 billion — significantly more companies raised multiple rounds compared to 2024, eight. How will 2026 compare? Elon Musk’s xAI announced a $20 billion Series E round and Sam Altman’s brain computer interface startup Merge Labs raised a $250 million seed round (with OpenAI as the lead investor) in the first few weeks of 2026, so signs point to another strong…
Everyone wants to know when AI investments will pay off.Most CEOs say they’re still waiting, according to PwC’s latest Global CEO survey, released on Monday to coincide with the start of Davos.The consulting giant questioned 4,454 chief executives across 95 countries and territories about their strategic priorities and outlook in the year up to November 2025.More than half of the CEOs surveyed, 56%, said AI hasn’t produced revenue or cost benefits for their businesses to date.Some reported benefits for either revenue or costs: around a third said their revenue was up in the last year, and 26% said they were…